Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

Clinical trial NCT06034561 · RECRUITING

Trial details

NCT number: NCT06034561
Sponsor: Instituto do Cancer do Estado de São Paulo
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Acute Lymphoblastic Leukemia With Failed Remission

Start date: 2024-04-01
Primary completion: 2028-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.